Trials / Conditions / Microscopic Colitis

Microscopic Colitis

16 registered clinical trials studyying Microscopic Colitis — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis in Clinical Rem NCT07156175	Sanofi	Phase 2
Enrolling By Invitation	Enabling Microbiomics- Driven Personalized Nutrition NCT06657001	Mayo Clinic	—
Active Not Recruiting	Chronic Diarrhea Owing to Underlying Microscopic Colitis NCT06530836	Zagazig University	—
Not Yet Recruiting	Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis NCT05915104	University of Calgary	Phase 2
Unknown	Faecal Microbiota Transplantation for Microscopic Colitis NCT05998174	Hvidovre University Hospital	EARLY_Phase 1
Terminated	Systems Biology of Gastrointestinal and Related Diseases NCT05579444	Viome	—
Unknown	Mucosa Adherent Intestinal Microbiome in Microscopic Colitis and Colorectal Cancer NCT06172647	Hospital Mutua de Terrassa	—
Unknown	External Validation of a Microscopic Colitis Clinical Scoring System in Patients With Chronic Watery Diarrhoea NCT06031064	Hospital Mutua de Terrassa	—
Unknown	Modulation of Intestinal Barrier Function and Inflammation Via Butyrate-promoting Dietary Fibre NCT05058131	Örebro University, Sweden	N/A
Recruiting	Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis NCT04043897	Eugene F Yen, MD	Phase 2
Unknown	FMT in Inflammatory Bowel Disease NCT03477032	St Vincent's Hospital Melbourne	—
Completed	Faecal Microbiota Transplantation in Patients With Microscopic Colitis NCT03275467	Örebro University, Sweden	N/A
Completed	Ussing Experiments to Evaluate the Role of Medication-induced Microscopic Colitis NCT02303132	Maastricht University Medical Center	N/A
Completed	Case-Control Study to Identify Risk Factors for Microscopic Colitis NCT01928667	Maastricht University Medical Center	—
Completed	Trial of Mesalamine for the Treatment of Active Microscopic Colitis NCT00952952	Mayo Clinic	Phase 2 / Phase 3
Completed	Budesonide Treatment for Lymphocytic Colitis NCT00180050	Technische Universität Dresden	Phase 3